Glaukos Corp (GKOS)
151.16
-1.51
(-0.99%)
USD |
NYSE |
Dec 27, 16:00
150.35
-0.81
(-0.54%)
After-Hours: 20:00
Glaukos Research and Development Expense (Quarterly): 34.75M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical Inc | 35.38M |
| Abbott Laboratories | 713.00M |
| Boston Scientific Corp | 407.00M |
| Intuitive Surgical Inc | 286.00M |
| Masimo Corp | 48.30M |